focus -WSS

focus

author：focus 2025-09-29 16:34:43 - browse：9

Two researchers look at a computer monitor showing a graph and other data — Adobe

Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： CZI to create biohub to build anti

WSS

ADCs take center stage as promising cancer treatments

ADCs take center stage as promising cancer treatments

Texas board proposes rules on abortion law emergency exemption

Pfizer, Moderna say biotech, pharma drug development is a sprint

STAT Summit: The economic case for universal basic health care

Cassava Sciences’ Alzheimer’s clinical trials should be halted

explore

focus

explore

New air purifier tech could be key to improving indoor air quality

Biotech investment managers search for lucrative opportunities

Novavax promises a turnaround & Lilly roils the obesity market

Chinese researcher claims birth of first gene

How one medical school became remarkably diverse

Surgeons perform first xenotransplant using CRISPR'd pig kidney

What does generative AI mean for health care? We asked experts

CRISPR technology availability, affordability needs to be expanded

Medical records are filled with copy

Cancer, immunology, HIV research ensnared in fetal tissue politics

knowledge

UnitedHealth, Optum discontinue NaviHealth name

U.K. officials, researchers try to ease path for bespoke genetic treatments

Pregnancy ages women, but effects reverse after delivery

Study on Amgen’s bispecific immunotherapy produces positive data

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Roche drug slashes death risk in early

hotspot

knowledge

Wikipedia

hotspot